Thieme
VC Fund
New York, United States
Thieme is a medical and science publisher that provides medical and chemistry information, software, and services to health professionals and students.The company's products include databases for medical student and resident education and board preparation, diagnostic imaging, nursing diagnosis as well as an organic chemical synthesis forthe pharmaceutical industry. Their services include programs for the management of chronic diseases. It also provides custom course software, and publishes journals and books annually in electronic and print form, and has an open-access program.It was founded in New York, New York by Georg Thieme in 1886.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Thieme invests in
Stages Thieme invests in
Countries Thieme invests in
Investment Focus
Industry
- Medical 2 (67%)
- Health Care 2 (67%)
- Sensor 1 (33%)
- Fitness 1 (33%)
- Software 1 (33%)
Stage
- Seed 2 (67%)
- Venture - Series Unknown 1 (33%)
Country
- Germany 2 (67%)
- Austria 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| XUND enables healthcare organizations to digitize patient interactions and turn data into actionable insights. Founded in 2018, the Vienna-based company provides better prevention, faster diagnosis and integrated monitoring with its Patient Interaction Suite.By leveraging cutting-edge Natural Language Processing (NLP) technology, we canautomatically analyze millions of medical publications to process data on 4,000+ condition concepts and thus reach unparalleled medical quality.The NLP technology results from more than 5 years of R&D and is a fundamental part of XUND's product development process as a medical device manufacturer. | $2.2M / Seed / Apr 02, 2024 | ||
| 8sense is the first smart back sensor and coach for the office, combining postion and movement analysis with realtime interaction and training. Games and challenges motivates you to take care about your back before it's too late. | Seed / Feb 15, 2019 | ||
| LifeTime has been developed by connected-health.eu GmbH since 2014 and has since grown into one of the leading and most secure solutions for digital delivery and decentralized management of medical data.LifeTime helps people better understand their health and treatment histories, as well as make their work more efficient, accurate and targetedfor doctors and healthcare workers. LifeTime was taken over by LifeTime GmbH on 1 August 2019 and will be further developed from now on under a new roof. | Venture - Series Unknown / Jan 12, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Thieme invest in?
Thieme invests primarily in Medical, Health Care and Sensor startups, most often at Seed and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Thieme last invest?
The most recent investment recorded for Thieme closed in Apr 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
